Los Angeles Capital Management’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.47M | Sell |
49,872
-3,555
| -7% | -$105K | 0.01% | 530 |
|
|
2025
Q1 | $1.59M | Buy |
53,427
+900
| +2% | +$26.9K | 0.01% | 448 |
|
|
2024
Q4 | $1.5M | Sell |
52,527
-4,700
| -8% | -$135K | 0.01% | 502 |
|
|
2024
Q3 | $2.21M | Sell |
57,227
-2,684
| -4% | -$104K | 0.01% | 435 |
|
|
2024
Q2 | $1.93M | Sell |
59,911
-6,029
| -9% | -$194K | 0.01% | 463 |
|
|
2024
Q1 | $2.56M | Sell |
65,940
-4,586
| -7% | -$178K | 0.01% | 443 |
|
|
2023
Q4 | $2.17M | Sell |
70,526
-6,350
| -8% | -$195K | 0.01% | 465 |
|
|
2023
Q3 | $1.72M | Buy |
76,876
+585
| +0.8% | +$13.1K | 0.01% | 485 |
|
|
2023
Q2 | $1.64M | Buy |
76,291
+5,023
| +7% | +$108K | 0.01% | 532 |
|
|
2023
Q1 | $1.71M | Sell |
71,268
-21,903
| -24% | -$525K | 0.01% | 537 |
|
|
2022
Q4 | $2.16M | Sell |
93,171
-45,847
| -33% | -$1.06M | 0.01% | 499 |
|
|
2022
Q3 | $2.23M | Buy |
139,018
+16,120
| +13% | +$258K | 0.01% | 480 |
|
|
2022
Q2 | $2.18M | Buy |
122,898
+23,379
| +23% | +$414K | 0.01% | 515 |
|
|
2022
Q1 | $2.03M | Buy |
+99,519
| New | +$2.03M | 0.01% | 530 |
|
|
2021
Q3 | – | Sell |
-21,871
| Closed | -$517K | – | 1491 |
|
|
2021
Q2 | $517K | Sell |
21,871
-1,200
| -5% | -$28.4K | ﹤0.01% | 1150 |
|
|
2021
Q1 | $547K | Sell |
23,071
-19,850
| -46% | -$471K | ﹤0.01% | 1176 |
|
|
2020
Q4 | $860K | Sell |
42,921
-1,595
| -4% | -$32K | ﹤0.01% | 1001 |
|
|
2020
Q3 | $927K | Sell |
44,516
-960
| -2% | -$20K | ﹤0.01% | 851 |
|
|
2020
Q2 | $796K | Buy |
45,476
+8,116
| +22% | +$142K | ﹤0.01% | 935 |
|
|
2020
Q1 | $610K | Buy |
+37,360
| New | +$610K | ﹤0.01% | 846 |
|
|
2018
Q3 | – | Sell |
-16,100
| Closed | -$384K | – | 1402 |
|
|
2018
Q2 | $384K | Buy |
+16,100
| New | +$384K | ﹤0.01% | 1212 |
|